New options for the treatment of obesity and type 2 diabetes mellitus (narrative review)
Authors:
Open Access
- 28 May 2013
- journal article
- review article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 27 (5) , 508-518
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Effect of Anti-Obesity Drug on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPLOS ONE, 2012
- Controlled‐Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)Obesity, 2012
- Standards of Medical Care in Diabetes—2012Diabetes Care, 2011
- Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 DiabetesDiabetes Care, 2011
- Obesity and Type 2 Diabetes: What Can Be Unified and What Needs to Be Individualized?Diabetes Care, 2011
- Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle interventionEuropean Journal of Endocrinology, 2011
- Long-term Effects of a Lifestyle Intervention on Weight and Cardiovascular Risk Factors in Individuals With Type 2 Diabetes MellitusArchives of internal medicine (1960), 2010
- Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 DiabetesDiabetes Care, 2007
- Mechanisms linking obesity to insulin resistance and type 2 diabetesNature, 2006
- Inflammation and insulin resistanceJournal of Clinical Investigation, 2006